Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. - sprookjes - yvandenbroek - TriplyDB

Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis.

Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis.

http://www.wikidata.org/entity/Q34312767

about

Microbial view of central nervous system autoimmunity Unexpected protective role for Toll-like receptor 3 in the arterial wall Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases Treatment of autoimmune inflammation by a TLR7 ligand regulating the innate immune system Models of autoimmune demyelination in the central nervous system: on the way to translational medicine.Neurogenesis-Promoting Natural Product α-Asarone Modulates Morphological Dynamics of Activated Microglia.TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen.Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9.Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis.Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis.Delayed onset of experimental autoimmune encephalomyelitis in Olig1 deficient mice.Inhibition of Myeloid Differentiation Factor 88 Reduces Human and Mouse T-Cell Interleukin-17 and IFNγ Production and Ameliorates Experimental Autoimmune Encephalomyelitis Induced in Mice IkappaB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-kappaB in the central nervous system Role of the innate immune system in the pathogenesis of multiple sclerosis.Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease.The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model IRAK-M deficiency promotes the development of type 1 diabetes in NOD mice.Humanized TLR7/8 expression drives proliferative multisystemic histiocytosis in C57BL/6 mice.Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function.Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity.Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosis.Recent developments in animal models for human herpesvirus 6A and 6B Toll-like receptors in multiple sclerosis.Streptococcus pneumoniae Infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2.Toll-like receptor signaling in neural plasticity and disease.Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice.Inactivation of JNK1 enhances innate IL-10 production and dampens autoimmune inflammation in the brain.TLR8: an innate immune receptor in brain, neurons and axons.Alteration of T cell cytokine production in PLPp-139-151-induced EAE in SJL mice by an immunostimulatory CpG oligonucleotide Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2 Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs)Comparison of a classical Th1 bacteria versus a Th17 bacteria as adjuvant in the induction of experimental autoimmune encephalomyelitis Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates.

P2860

Q22252213-9038C2AC-04B9-4F25-A24B-BD1DDCA1A0E7 Q24624935-679F88C3-7EE4-4241-AC3C-E601F422AF8E Q26745562-AF5F2506-1D44-423C-B2C9-217CB8EBCE9F Q26770257-C3777F34-BB78-4DB3-92BB-85F7DCE568B5 Q28484146-0BE8A709-BB96-4643-9C4E-704ED5BEBD7D Q30483471-D2EF506E-02B9-405C-84CB-9AA0EA548858 Q30831348-ECB25AFF-4068-4A8E-8507-150933F1E0F8 Q33281667-D9858C24-C058-47A9-9784-D713BAD08FD1 Q33416725-E9D5D01A-E6DA-4566-9D6A-C284112EE064 Q33602699-374CB121-98DF-487D-8397-542CD36B950E Q33625018-93353E88-A040-48DC-A992-82EF4BB66C0C Q33670387-3BA7B892-1E45-4AFC-90D9-18DFB420945E Q33711938-A1C52772-3A79-474B-83FB-EBE7A078B9F4 Q33734635-3F9FD663-BA48-4086-8D8E-8F998CDD428F Q33749325-391DD642-9D25-4E86-99B1-AB6C4360C8FD Q33787624-8588661E-CAF1-45C7-9054-DB26D85DFD9D Q33789063-EEF8E213-E764-4019-9B30-A54712E199E9 Q33802616-3E1EAE08-61BC-499F-8B25-C16B25DD2F90 Q33886694-5BEA344A-2E0F-46D4-9D12-95544F50DAE6 Q33938242-0E3FE6C1-7DDB-4407-A3DD-FE835861101C Q33959795-3F9FFBE6-EEB6-4FB1-A85F-161E74ECDDB9 Q34208023-F4118E0D-5D29-4314-B07A-22D20DB0CC34 Q34344447-E88F74A4-6869-4EB2-9AB6-B6D9A4F8B3FA Q34417523-81B14569-181D-4738-9ECE-4E1BF29B680B Q34510368-912509D4-A5C2-4E72-AA66-66237AF17466 Q34630040-23D571D4-8215-4791-898D-D55781A43E5F Q34673043-BEAA20F6-A163-4728-9AC0-2B86018D7A41 Q34695691-47D8E7BE-AFC4-4214-B15A-F541AE5693F5 Q34717973-550A4665-510C-4C29-9788-7889FD843BD7 Q34721972-23761A1C-8A9F-4120-8710-0754E74A470B Q34975805-AFBF36C1-2F27-4CB7-8EED-BBA2CA403A9D Q34984865-F1AA2804-03E7-4D2A-A424-8EF3386979CA Q35005601-3CF89499-A9E9-4A5C-A808-9F50B0AC7097 Q35037296-6527BA40-6C93-4EE2-8D77-774889D19E3B Q35047901-68C7816D-60D1-451A-9304-82E3FC690197 Q35078163-5043A205-FBFF-4A2C-A332-51A7D00A2E8A Q35096502-0E64C23C-BC0A-4FF1-9253-242A48B92DEE Q35105181-39360F68-168B-4CE5-819C-B071C70D162A Q35165584-1EAF9CE2-4F3B-4FC4-A991-68361A19D67D Q35607368-09011246-E932-49B0-98A1-5DA81798969F

P2860

Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis.

http://www.wikidata.org/entity/Q34312767

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Innate immunity mediated by TL ...... l model of multiple sclerosis.

@ast

Innate immunity mediated by TL ...... l model of multiple sclerosis.

@en

Innate immunity mediated by TL ...... l model of multiple sclerosis.

@nl

type

label

Innate immunity mediated by TL ...... l model of multiple sclerosis.

@ast

Innate immunity mediated by TL ...... l model of multiple sclerosis.

@en

Innate immunity mediated by TL ...... l model of multiple sclerosis.

@nl

prefLabel

Innate immunity mediated by TL ...... l model of multiple sclerosis.

@ast

Innate immunity mediated by TL ...... l model of multiple sclerosis.

@en

Innate immunity mediated by TL ...... l model of multiple sclerosis.

@nl

P1433

Q34312767-2E1A5C25-16FF-4DE8-BAFA-B777AC9EE1A3

P1476

Q34312767-F9C8A7BB-9428-4907-874E-0FC2454BADF9

P2093

Q34312767-40F4C7C2-F9A6-4D86-A2B3-5835CFBA7802

Q34312767-4294F711-B59B-4088-BB87-C307725D98FD

Q34312767-497C14A0-69FE-496F-98BE-66D3EF1F97DE

Q34312767-623FEE83-AB75-48E5-911D-45C490DDEB9D

Q34312767-7DAE76CD-02E9-447F-9677-0E9620D2895B

Q34312767-8514862C-E436-4F3C-AE44-6AF4E7D0F0A3

Q34312767-8A2A9E52-A4F3-482A-B6D6-FB2E40B63418

Q34312767-8F493DBC-1BFD-4CDC-A9BD-BC95A1949156

Q34312767-AF74A462-F584-4C55-B6AB-3152DED523CB

Q34312767-CCDDEDAF-BB00-40B7-85E9-4669000E7729

P2860

Q34312767-00A185E6-3154-402C-AB06-B4BB36176776

Q34312767-01AD6054-368E-4AAD-93D5-EAEA0725F2F4

Q34312767-04F5D07F-B130-4F41-9BE1-B76A3359968F

Q34312767-0AA9BC90-AE01-4A6C-B0A4-F4A8863E6D5B

Q34312767-12984DC3-03E7-4768-9339-5D46CC737BAC

Q34312767-171579BB-2CC7-4914-9EE3-2A859F8CD188

Q34312767-1C4C0349-EAED-4CC5-884C-ED48BD81C9BB

Q34312767-1C57E510-97A8-493A-9F2E-25A7799E7444

Q34312767-290B6B7F-202D-4319-8E69-46FC3EE836F6

Q34312767-303CEB9D-C51F-445B-A212-7DC3FFB37859

P304

Q34312767-6BB396F1-4D7E-4B3E-9234-49117B4004B6

P31

Q34312767-620A2FD5-B6FB-410F-9580-25618F7C13BD

P356

Q34312767-7E1C6D80-EAA9-4769-A7FD-750C3836804B

P407

Q34312767-1483AD09-1885-4305-9C3D-6C664C04B1C9

P433

Q34312767-40752AE0-0EBB-4DA3-B338-D406CD8C77A6

P478

Q34312767-2B0EB63D-D7A9-4E70-9B43-CB8914E34E0F

P50

Q34312767-09F55368-3FAF-4DC3-ABA4-5852B6E16EEE

Q34312767-36EB2B09-469C-47A2-9BFB-48AD5C5A48F6

P577

Q34312767-F3078755-D250-4A2C-8574-E8487F10F730

P698

Q34312767-22BAB9FB-EF97-4B26-86F5-911428BD61A8

P921

Q34312767-28633F55-612D-4DD6-A7FF-84E18FE62753

Q34312767-9BE3A1FB-0928-484A-B66A-2BFD32A766E7

P932

Q34312767-481EC798-2596-4820-8CE1-7B386F07442B

P356

P1433

Journal of Clinical Investigation

P1476

Innate immunity mediated by TL ...... l model of multiple sclerosis.

@en

P2093

Burkhard Becher

http://www.w3.org/2001/XMLSchema#string

Carsten J Kirschning

http://www.w3.org/2001/XMLSchema#string

Christian D P Rochford

http://www.w3.org/2001/XMLSchema#string

Elisabeth Weiss

http://www.w3.org/2001/XMLSchema#string

Folker Garbe

http://www.w3.org/2001/XMLSchema#string

Hauke Schmidt

http://www.w3.org/2001/XMLSchema#string

Ilona Gutcher

http://www.w3.org/2001/XMLSchema#string

Karina Wolter

http://www.w3.org/2001/XMLSchema#string

Marco Prinz

http://www.w3.org/2001/XMLSchema#string

Roland Schroers

http://www.w3.org/2001/XMLSchema#string

P2860

A Toll-like receptor recognizes bacterial DNA

Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs

IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling

Dendritic cells and the control of immunity

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

Multiple sclerosis

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults

Toll-like receptors in innate immunity

Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades

P304

456-464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI26078

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Mildner

Matthias Piesche

P577

2006-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16440059

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

multiple sclerosis

P932

1350999

http://www.w3.org/2001/XMLSchema#string